Literature DB >> 23707765

Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.

Xiuming Song1, Jing Yao, Fei Wang, Mi Zhou, Yuxin Zhou, Hu Wang, Libin Wei, Li Zhao, Zhiyu Li, Na Lu, Qinglong Guo.   

Abstract

Wogonin, a plant-derived flavone, has been shown recently to have antitumor effects. However, the mechanisms that wogonin inhibits tumor angiogenesis are not well known. In this study, we investigated the effects of wogonin on expression of hypoxia-inducible factor-1α (HIF-1α) and secretion of vascular endothelial growth factor (VEGF) in tumor cells. We found that wogonin decreased the expression of HIF-1α by affecting its stability and reduced the secretion of VEGF, which suppressed angiogenesis in cancer. Wogonin promoted the degradation of HIF-1α by increasing its prolyl hydroxylation, which depended on prolyl hydroxylase (PHD) and the von Hippel-Lindau tumor suppressor (VHL). Intriguingly, wogonin impeded the binding between heat-shock protein 90 (Hsp90) and HIF-1α. In addition, wogonin down-regulated the Hsp90 client proteins EGFR, Cdk4 and survivin, but did not affect the level of Hsp90. Wogonin also increased ubiquitination of HIF-1α and promoted its degradation in proteasome. We also found that wogonin could inhibit nuclear translocation of HIF-1α. Electrophoresis mobility shift assay (EMSA) showed that wogonin decreased the binding activity of exogenous consensus DNA oligonucleotide with HIF-1α in nuclear extracts from MCF-7 cells. Chromatin immunoprecipitation (ChIP) assay also revealed that HIF-1α directly binded to endogenous hypoxia-responsive element (HRE) and this binding was significantly decreased in MCF-7 cells treated with wogonin. Preliminary results indicated in vivo activity of wogonin against xenograft-induced angiogenesis in nude mice. Taken together, the results suggested that wogonin was a potent inhibitor of HIF-1α and provided a new insight into the mechanisms of wogonin against cancers.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; CAM; CHX; ChIP; DMOG; Degradation; ELISA; EMSA; HIF-1α; HRE; HUVEC; Hsp90; Hypoxia-inducible factor-1α (HIF-1α); ODDD; PHD; RACK1; VEGF; VHL; Wogonin; activated protein kinase C; chicken chorioallantoic membrane; chromatin immunoprecipitation assay; cycloheximide; dimethyloxalylglycine; electrophoretic mobility shift assays; enzyme linked immunosorbent assay; heat-shock protein 90; human umbilical vein endothelial cell; hypoxia-inducible factor-1α; hypoxic response element; prolyl hydroxylase; the oxygen-dependent degradation domain; the von Hippel–Lindau tumor suppressor; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 23707765     DOI: 10.1016/j.taap.2013.04.031

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  22 in total

Review 1.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

2.  Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway.

Authors:  Jing Yao; Di Pan; Yue Zhao; Li Zhao; Jie Sun; Yu Wang; Qi-Dong You; Tao Xi; Qing-Long Guo; Na Lu
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

3.  Wogonin prevents rat dorsal root ganglion neurons death via inhibiting tunicamycin-induced ER stress in vitro.

Authors:  Shujuan Xu; Xin Zhao; Quanlai Zhao; Quan Zheng; Zhen Fang; Xiaoming Yang; Hong Wang; Ping Liu; Hongguang Xu
Journal:  Cell Mol Neurobiol       Date:  2014-11-09       Impact factor: 5.046

4.  Wogonin protects rat dorsal root ganglion neurons against tunicamycin-induced ER stress through the PERK-eIF2α-ATF4 signaling pathway.

Authors:  Fangyi Chen; Rongbo Wu; Zhu Zhu; Wangping Yin; Min Xiong; Jianwei Sun; Miaozhong Ni; Guoping Cai; Xinchao Zhang
Journal:  J Mol Neurosci       Date:  2014-11-23       Impact factor: 3.444

5.  Wogonin inhibits LPS-induced inflammatory responses in rat dorsal root ganglion neurons via inhibiting TLR4-MyD88-TAK1-mediated NF-κB and MAPK signaling pathway.

Authors:  Shibiao Chen; Jiangqin Xiong; Yanping Zhan; Weicheng Liu; Xiuhong Wang
Journal:  Cell Mol Neurobiol       Date:  2014-12-14       Impact factor: 5.046

6.  Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

Authors:  Mark J de Keijzer; Daniel J de Klerk; Lianne R de Haan; Robert T van Kooten; Leonardo P Franchi; Lionel M Dias; Tony G Kleijn; Diederick J van Doorn; Michal Heger
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

8.  Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma.

Authors:  Hongming Teng; Yazong Yang; Hengyun Wei; Zundong Liu; Zhichao Liu; Yanhong Ma; Zixiang Gao; Lin Hou; Xiangyang Zou
Journal:  Mar Drugs       Date:  2015-06-03       Impact factor: 5.118

9.  In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.

Authors:  Xiaolu Liu; Yuling Fan; Lipeng Du; Zhigang Mei; Yang Fu
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

Review 10.  The Therapeutic Potential of Wogonin Observed in Preclinical Studies.

Authors:  Javad Sharifi-Rad; Jesús Herrera-Bravo; Luis A Salazar; Shabnum Shaheen; Seyed Abdulmajid Ayatollahi; Farzad Kobarfard; Muhammad Imran; Ali Imran; Luísa Custódio; María Dolores López; Mauricio Schoebitz; Miquel Martorell; Manoj Kumar; Hafiz Ansar Rasul Suleria; William C Cho
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.